Fetal Anomaly Clinical Trial
Official title:
Fetal Brain Sonographic Measurements and Normograms in Healthy Fetuses During Second and Third Trimesters
The aim of our study is to determine the range of frontal horn sizes (both upside and downside) in healthy fetuses over gestation and to determine how far FHs are from the midline . Also to determine the range of cavum septi pellucidi and Corpus callosum sizes . Also, to determine whether the maternal body mass index (BMI) affects rates of visualized and non-visualized CSP and CC.
Fetal central nervous system (CNS) abnormalities are among the most commonly encountered congenital abnormalities . Many different methods can be used to obtain prenatal diagnoses, including ultrasound (US), which is one of the most commonly used methods .Neonatal survival rates have increased over the last decades leading to increased number of infants with adverse neurodevelopmental outcomes, including cognitive, motor impairments and behavioral and learning difficulties later in life . Recent studies demonstrated that signs of abnormal neurological development are already present at birth . Frontal horns (FHs) are the most anterior portions of the lateral ventricles, on each side the cavum septi pellucidi (CSP). In accordance with practice parameters released as early as 1985 by the American Institute of Ultrasound in Medicine, American College of Obstetrics and Gynecology, and Society of Radiologists in Ultrasound, the CSP is examined in screening fetal ultrasound (US) examinations in the biparietal diameter view . Frontal horns (FH) are also visualized in the same plane. Abnormal morphologic characteristics of the FHs such as enlargement, squaring, spearing, and splaying may have an association with congenital intracranial anomalies such as holoprosencephaly, schizencephaly and agenesis of the corpus callosum . The corpus callosum (CC) is the largest interhemispheric white matter commissure of the human brain . It is a sensitive indicator of normal brain development and maturation ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02965287 -
Validation of a Test for Fetal Malformations
|
||
Completed |
NCT05527327 -
Pannus Retraction for Ultrasound Evaluation of the Obese Gravida: A Pilot Study
|
N/A | |
Completed |
NCT05655741 -
Modified Delphi for Genomic Bereavement Care
|
||
Enrolling by invitation |
NCT03412760 -
Hydrops: Diagnosing & Redefining Outcomes With Precision Study
|
N/A | |
Recruiting |
NCT05790473 -
Artificial Intelligence Algorithm for the Screening of Abnormal Fetal Brain Findings at First Trimester Ultrasound Scan
|
||
Recruiting |
NCT03398629 -
Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies
|
||
Completed |
NCT05764408 -
Pannus Assistance Needed for Obstetric Ultrasound Studies
|
N/A | |
Not yet recruiting |
NCT04897178 -
Machine Learning-based Anomaly Recognition System
|
||
Completed |
NCT02664207 -
Extended Criteria For Fetal Myelomeningocele Repair
|
N/A | |
Completed |
NCT02875860 -
'TOTAL' (Tracheal Occlusion To Accelerate Lung Growth) Trial
|
Phase 2 | |
Completed |
NCT05785338 -
Trial Observationnal
|
||
Completed |
NCT03795857 -
Antenatal Palliative Care
|
||
Completed |
NCT04174235 -
Prevalence of Fetal Congenital Anomalies Among Pregnant Women Attending University Hospital
|
||
Completed |
NCT03544970 -
An Audit of the Posterior Fossa Characterization in Open Spina Bifida Based on Tertiary Center Experience
|